Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D DeMarco

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Bioconjugate Chemistry|September 17, 2025
SPARC: A Multipayload ADC Architecture for Programmable Drug CombinationsWenlong Sun, Weining Weng, Jing Shi, et al.
Biorxiv : the Preprint Server for Biology|August 2, 2024
MYC and p53 alterations cooperate through VEGF signaling to repress cytotoxic T cell and immunotherapy responses in prostate cancerKatherine C Murphy, Kelly D DeMarco, Lin Zhou, et al.
Vaccine|July 6, 2010
Immune response to hepatitis B vaccine in HIV-infected subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG study 5220E T Overton, M Kang, M G Peters, et al.
Cancer Research|September 3, 2025
MYC and p53 Alterations Cooperate through VEGF Signaling to Repress Cytotoxic T Cell and Immunotherapy Responses in Prostate CancerKatherine C Murphy, Kelly D DeMarco, Lin Zhou, et al.
Biorxiv : the Preprint Server for Biology|October 4, 2023
Nanoparticle delivery of innate immune agonists combines with senescence-inducing agents to mediate T cell control of pancreatic cancerLoretah Chibaya, Christina F Lusi, Kelly D DeMarco, et al.
Cancer Discovery|October 24, 2025
P21-positive senescent stromal cells promote prostate cancer immune suppression and progression that can be reversed by senolytic therapyLin Zhou, Kelly D DeMarco, Katherine C Murphy, et al.
Nature Cancer|May 4, 2023
EZH2 inhibition remodels the inflammatory senescence-associated secretory phenotype to potentiate pancreatic cancer immune surveillanceLoretah Chibaya, Katherine C Murphy, Kelly D DeMarco, et al.
Science Translational Medicine|August 28, 2024
Nanoparticle delivery of innate immune agonists combined with senescence-inducing agents promotes T cell control of pancreatic cancerLoretah Chibaya, Kelly D DeMarco, Christina F Lusi, et al.
Nature Communications|June 19, 2026
Multiplexed cytokine and antigen mRNA administration generates durable anti-tumor immunity against pancreatic cancerChaitanya N Parikh, Kelly D DeMarco, Nikita Bhalerao, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 22, 2025
PPT1 is a negative regulator of STING signaling in cancer cells and its inhibition reactivates immune surveillance in cold tumorsShreya R Chowdhury, Chaitanya N Parikh, Arshia N Kaur, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Bioconjugate Chemistry|September 17, 2025
SPARC: A Multipayload ADC Architecture for Programmable Drug CombinationsWenlong Sun, Weining Weng, Jing Shi, et al.
Biorxiv : the Preprint Server for Biology|August 2, 2024
MYC and p53 alterations cooperate through VEGF signaling to repress cytotoxic T cell and immunotherapy responses in prostate cancerKatherine C Murphy, Kelly D DeMarco, Lin Zhou, et al.
Vaccine|July 6, 2010
Immune response to hepatitis B vaccine in HIV-infected subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG study 5220E T Overton, M Kang, M G Peters, et al.
Cancer Research|September 3, 2025
MYC and p53 Alterations Cooperate through VEGF Signaling to Repress Cytotoxic T Cell and Immunotherapy Responses in Prostate CancerKatherine C Murphy, Kelly D DeMarco, Lin Zhou, et al.
Biorxiv : the Preprint Server for Biology|October 4, 2023
Nanoparticle delivery of innate immune agonists combines with senescence-inducing agents to mediate T cell control of pancreatic cancerLoretah Chibaya, Christina F Lusi, Kelly D DeMarco, et al.
Cancer Discovery|October 24, 2025
P21-positive senescent stromal cells promote prostate cancer immune suppression and progression that can be reversed by senolytic therapyLin Zhou, Kelly D DeMarco, Katherine C Murphy, et al.
Nature Cancer|May 4, 2023
EZH2 inhibition remodels the inflammatory senescence-associated secretory phenotype to potentiate pancreatic cancer immune surveillanceLoretah Chibaya, Katherine C Murphy, Kelly D DeMarco, et al.
Science Translational Medicine|August 28, 2024
Nanoparticle delivery of innate immune agonists combined with senescence-inducing agents promotes T cell control of pancreatic cancerLoretah Chibaya, Kelly D DeMarco, Christina F Lusi, et al.
Nature Communications|June 19, 2026
Multiplexed cytokine and antigen mRNA administration generates durable anti-tumor immunity against pancreatic cancerChaitanya N Parikh, Kelly D DeMarco, Nikita Bhalerao, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 22, 2025
PPT1 is a negative regulator of STING signaling in cancer cells and its inhibition reactivates immune surveillance in cold tumorsShreya R Chowdhury, Chaitanya N Parikh, Arshia N Kaur, et al.
Pageof 3